SPORTS MEDICINE RESEARCH AND TESTI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

CHRIS WEST

Phone

8019949454

Tax Period

2024-07-01 to 2025-06-30

SPORTS MEDICINE RESEARCH AND TESTING LAB, founded in 2003, is a mid-sized nonprofit in the Medical Research sector that reported $24.6M in total revenue in fiscal year 2024. Revenue surged 26% from the prior year, signaling strong growth momentum. The organization ran a surplus of $8.4M, a strong 34% operating margin.

Mission

THE CORPORATION'S MISSION IS TO PROMOTE THE PUBLIC'S HEALTH AND SAFETY THROUGH RIGOROUS TESTING OF SUBSTANCES THAT ENDANGER ONE'S HEALTH.

Program Service Accomplishments

Program 1

Expenses: $7,756,791 Revenue: $18,971,043

SMRTL IS ACTIVELY ENGAGED IN TESTING FOR SUBSTANCES THAT ENDANGER THE PUBLIC'S HEALTH AND SAFETY. MANY OF OUR TESTS ARE PERFORMED ON PROFESSIONAL AND AMATEUR ATHLETES SUBJECT TO THE ANTI-DOPING...

SMRTL IS ACTIVELY ENGAGED IN TESTING FOR SUBSTANCES THAT ENDANGER THE PUBLIC'S HEALTH AND SAFETY. MANY OF OUR TESTS ARE PERFORMED ON PROFESSIONAL AND AMATEUR ATHLETES SUBJECT TO THE ANTI-DOPING PROGRAMS MANAGED BY THEIR SPONSORS. MANY OTHER TESTS ARE PERFORMED FOR NONPROFIT AND GOVERNMENTAL ENTITIES WITHOUT CHARGE OR AT REDUCED RATES. SMTRL PERFORMED OVER 65,000 TESTS DURING THE LAST YEAR.

Program 2

Expenses: $305,559 Revenue: $0

SMRTL IS ENGAGED IN RESEARCH AND DEVELOPMENT OF IDENTIFYING NEW METHODS OF DETECTION. DURING THE YEAR, SMRTL CONDUCTED SEVERAL GRANT-FUNDED RESEARCH AND DEVELOPMENT PROJECTS FOCUSED ON NEW ANALYTICAL METHODS, HUMAN DRUG ADMINISTRATION AND PHARMACOKINETIC STUDIES, ANALYSIS OF TESTING PATTERNS IN ATHLETES AND OTHER PARTIES AND NOVEL APPROACHES FOR ASSESSING DRUG USE BY ATHLETES AND OTHER PARTIES. SMRTL ALSO PROVIDES EDUCATIONAL SERVICES IN THE FORM OF PRESENTATIONS AT SCIENTIFIC MEETINGS AND ASSISTANCE TO TESTING PROGRAM ADMINISTRATORS. SMRTL ALSO ACTS IN AN ADVISORY CAPACITY TO THE WORLD ANTI-DOPING AGENCY SITTING ON VARIOUS WORKING GROUPS THAT FORM ATHLETE DRUG TESTING POLICIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $18,971,043

Investment Income $4,869,680

Other Revenue $747,461

TOTAL REVENUE $24,588,184

Expense Breakdown

Grants Paid $0

Salaries & Benefits $8,492,850

Fundraising Expenses $0

Program Expenses $8,062,350

Other Expenses $7,701,290

TOTAL EXPENSES $16,194,140

Year-over-Year Comparison

	2024	2023	Change
Revenue	$24,588,184	$19,505,868	+0.3%
Expenses	$16,194,140	$14,407,792	+0.1%
Net Income	$8,394,044	$5,098,076	+0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$858,271

Total Directors

$31,500

Key Employees

$335,681

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN LOMBARDO MD	DIRECTOR	2.00	Director	$4,500	$0	$4,500
JACK HENION PHD	DIRECTOR	2.00	Director	$4,500	$0	$4,500
TOM KUPIEC PHD	DIRECTOR	2.00	Director	$4,500	$0	$4,500
MARILYN HUESTIS PHD	DIRECTOR	2.00	Director	$4,500	$0	$4,500
CAROLAYNE HENRY	DIRECTOR	2.00	Director	$4,500	$0	$4,500
MICHELLE PUJALS	DIRECTOR	2.00	Director	$4,500	$0	$4,500
LAWRENCE LAMADE	CHAIRMAN	2.00	Officer Director	$4,500	$0	$4,500
DANIEL EICHNER PHD	PRESIDENT/LAB DIRECTOR	40.00	Officer	$581,028	$41,086	$622,114
CHRIS WEST	CFO	40.00	Officer	$208,067	$23,590	$231,657
THANE CAMPBELL	COO	40.00	Key Emp	$310,426	$25,255	$335,681
VINOD NAIR PHD	ASSOCIATE LAB DIRECTOR	40.00	Highest	$197,906	$23,590	$221,496
RYAN VAN WAGONER PHD	SENIOR SCIENTIST	40.00	Highest	$185,172	$23,590	$208,762
CHAD MOORE PHD	ASSIST LAB DIRECTOR	40.00	Highest	$167,015	$7,506	$174,521
GEOFF MILLER PHD	ASSIST LAB DIRECTOR	40.00	Highest	$169,578	$15,812	$185,390

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$24,588,184	$16,194,140	$95,518,403	$8,394,044
2024	$19,505,868	$14,407,792	$85,217,330	$5,098,076
2023	$14,973,918	$12,035,961	$76,991,416	$2,937,957
2022	$12,924,989	$13,667,693	$73,882,165	$-742,704
2022	$12,924,989	$13,667,693	$73,882,165	$-742,704
2021	$82,704,534	$30,109,241	$85,311,442	$52,595,293
2020	$9,813,945	$9,354,586	$31,790,739	$459,359
2019	$11,716,266	$7,972,506	$22,648,803	$3,743,760

SPORTS MEDICINE RESEARCH AND TESTING LAB